Tekla Capital Management LLC - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 13 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 6.9%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$9,734,000
-0.1%
13,000,0000.0%0.42%
+18.1%
Q3 2018$9,740,000
+15.5%
13,000,0000.0%0.35%
+10.3%
Q2 2018$8,436,000
-15.7%
13,000,0000.0%0.32%
-17.7%
Q1 2018$10,010,000
-3.1%
13,000,0000.0%0.39%
-2.5%
Q4 2017$10,335,000
+0.3%
13,000,0000.0%0.40%
+8.4%
Q3 2017$10,303,000
-2.3%
13,000,0000.0%0.37%
-5.9%
Q2 2017$10,546,000
+1.4%
13,000,0000.0%0.39%
-3.0%
Q1 2017$10,400,000
+12.3%
13,000,0000.0%0.40%
+2.0%
Q4 2016$9,263,000
+8.1%
13,000,0000.0%0.40%
+19.7%
Q3 2016$8,572,000
+15.7%
13,000,0000.0%0.33%
+9.3%
Q2 2016$7,410,000
+12.2%
13,000,0000.0%0.30%
+7.5%
Q1 2016$6,606,000
-23.4%
13,000,0000.0%0.28%
-10.2%
Q4 2015$8,629,000
-76.6%
13,000,0000.0%0.31%
-76.3%
Q3 2015$36,801,00013,000,0001.32%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Context Capital Management, LLC 1,760,000$898,0001.12%
Telemetry Investments, L.L.C. 6,000,000$3,049,0000.89%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 54,500,000$27,693,0000.46%
ZAZOVE ASSOCIATES LLC 15,070,000$7,761,0000.37%
ACUTA CAPITAL PARTNERS, LLC 1,000,000$508,0000.28%
Tekla Capital Management LLC 13,000,000$6,606,0000.28%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 26,000,000$13,910,000,0000.26%
Castle Creek Arbitrage, LLC 4,000,000$2,081,0000.17%
WOLVERINE ASSET MANAGEMENT LLC 10,934,000$5,558,0000.16%
Baker Brothers Advisors 26,517,000$13,526,0000.14%
View complete list of AEGERION PHARMACEUTICALS INC shareholders